Dossier+ Memberships
Perfume maker’s subscription disclosures don’t pass the smell test.
A class action was filed against Bayer for marketing its Women’s Low-Dose Aspirin plus Calcium and its Aspirin with Heart Advantage without FDA approval. The lawsuit also alleged that Bayer’s combination aspirin products could not provide all the advertised health benefits and were not suitable for long-term use. In October 2012, Bayer agreed to pay $15 million to resolve the case. (In re: Bayer Corp. Combination Aspirin Products Marketing & Sales Practices Litigation, Case No. 1:2009md02023)
Perfume maker’s subscription disclosures don’t pass the smell test.
Exploring the MLM industry’s latest pivot.
Callum Bains, THe Guardian
TINA.org observes Military Consumer Month the only way we know how – by sharing deceptive ads.
TINA.org looks into the math behind company’s environmental claim.